{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:06:21Z","timestamp":1794405981440,"version":"4.9.0"},"reference-count":80,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"abstract":"<jats:p>\n                    Ulcerative colitis (UC) involves dysregulated immune responses and metabolic reprogramming, yet the causal mechanisms linking inflammatory mediators to UC via metabolic intermediates remain elusive. This study employs integrated Mendelian randomization (MR) and mediation analysis to dissect the immune-metabolic axis, a novel conceptual framework for UC pathogenesis, where inflammatory factors exert causal effects through metabolite-mediated pathways. Using European genetic data (5931 UC cases; 405,386 controls), we performed bidirectional 2-sample MR to assess causal relationships between 91 inflammatory factors, 1400 plasma metabolites, and UC. Genetic instruments were selected stringently (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u20051\u2005\u00d7\u200510\u207b\n                    <jats:sup>5<\/jats:sup>\n                    ,\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    \u2005&lt;\u20050.001). Causal estimates were generated via inverse-variance weighted regression, with sensitivity analyses (MR-Egger, weighted median). A 2-stage MR mediation framework quantified metabolite-driven pathways linking inflammatory factors to UC. Six inflammatory factors showed causal effects on UC: IL10RB (odds ratio [OR]\u2005=\u20051.15,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.011) and CCL4 (OR\u2005=\u20051.12,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.008) increased risk, while Flt3L, CCL8, CCL11, and PD-L1 were protective (OR range: 0.85\u20130.90,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Metabolomic analysis identified 21 causal metabolites, including docosahexaenoic acid-enriched phosphatidylcholines (e.g., 16:0\/22:6, OR\u2005=\u20050.858) and linoleate-derived lipids (e.g., 18:0\/18:2, OR\u2005=\u20051.262). Crucially, mediation models revealed bidirectional immune-metabolic crosstalk. CCL4 increased UC risk by suppressing protective ether lipids (e.g., p-18:0\/20:4; mediation proportion: 8.6%). IL10RB paradoxically offset its direct proinflammatory effect by upregulating tetradecadienoate (14:2), reducing UC risk (mediation proportion: \u221211.7%). This study establishes genetic evidence for an immune-metabolic axis in UC, wherein inflammatory mediators operate through metabolite-dependent pathways. The identified mediation proportions quantify the contribution of metabolic rewiring to UC pathogenesis, revealing novel targets for therapeutic intervention.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044206","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:01:14Z","timestamp":1757970074000},"page":"e44206","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Mendelian randomization study: Metabolites as mediators of inflammatory factors in ulcerative colitis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4965-3290","authenticated-orcid":false,"given":"Meiqi","family":"Cai","sequence":"first","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6119-625X","authenticated-orcid":false,"given":"Yuedong","family":"Liu","sequence":"additional","affiliation":[{"name":"Third Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwu","family":"Tao","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Tang","sequence":"additional","affiliation":[{"name":"Gansu Medical College, Pingliang, Gansu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Third Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiru","family":"Lan","sequence":"additional","affiliation":[{"name":"Third Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewei","family":"Sheng","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyu","family":"Peng","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanni","family":"Sun","sequence":"additional","affiliation":[{"name":"Third Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianshu","family":"Wu","sequence":"additional","affiliation":[{"name":"Third Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Shu","sequence":"additional","affiliation":[{"name":"People\u2019s Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260923","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: medical treatment.","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis"},{"key":"R2-20260923","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2468-1253(17)30032-8","article-title":"Colon cancer in Asian patients with ulcerative colitis.","volume":"2","author":"Kaplan","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R3-20260923","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.gtc.2020.07.005","article-title":"Epidemiology and pathogenesis of ulcerative colitis.","volume":"49","author":"Du","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"R4-20260923","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis.","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"key":"R5-20260923","doi-asserted-by":"crossref","first-page":"103655","DOI":"10.1016\/j.autrev.2024.103655","article-title":"Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: data from 1990 to 2019.","volume":"23","author":"Dou","year":"2024","journal-title":"Autoimmun Rev"},{"key":"R6-20260923","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1038\/s41598-025-89252-1","article-title":"Identification of the immune infiltration and biomarkers in ulcerative colitis based on liquid-liquid phase separation-related genes.","volume":"15","author":"Hong","year":"2025","journal-title":"Sci Rep"},{"key":"R7-20260923","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s43556-024-00207-w","article-title":"Ulcerative colitis: molecular insights and intervention therapy.","volume":"5","author":"Liang","year":"2024","journal-title":"Mol Biomed"},{"key":"R8-20260923","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/nu13010135","article-title":"The role of diet in the pathogenesis and management of inflammatory bowel disease: a review.","volume":"13","author":"Wark","year":"2020","journal-title":"Nutrients"},{"key":"R9-20260923","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41564-021-01050-3","article-title":"Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity.","volume":"7","author":"Mills","year":"2022","journal-title":"Nat Microbiol"},{"key":"R10-20260923","first-page":"559","article-title":"Short-chain fatty acids and human health: from metabolic pathways to current therapeutic implications.","volume":"14","author":"Facchin","year":"2024","journal-title":"Life (Basel)"},{"key":"R11-20260923","first-page":"1","article-title":"Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats.","volume":"51","author":"Zhao","year":"2019","journal-title":"Exp Mol Med"},{"key":"R12-20260923","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40168-018-0433-4","article-title":"High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production.","volume":"6","author":"Miranda","year":"2018","journal-title":"Microbiome"},{"key":"R13-20260923","doi-asserted-by":"crossref","first-page":"1238457","DOI":"10.3389\/fimmu.2023.1238457","article-title":"Interleukin-17 and inflammatory bowel disease: a 2-sample Mendelian randomization study.","volume":"14","author":"Cai","year":"2023","journal-title":"Front Immunol"},{"key":"R14-20260923","doi-asserted-by":"crossref","first-page":"111898","DOI":"10.1016\/j.isci.2025.111898","article-title":"IL-23 tunes inflammatory functions of human mucosal-associated invariant T cells.","volume":"28","author":"Camard","year":"2025","journal-title":"iScience"},{"issue":"Supplement_2","key":"R15-20260923","doi-asserted-by":"crossref","first-page":"ii64","DOI":"10.1093\/ecco-jcc\/jjab185","article-title":"Blockade of IL-23: what is in the pipeline.","volume":"16","author":"Parigi","year":"2022","journal-title":"J Crohns Colitis"},{"key":"R16-20260923","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3389\/fimmu.2019.01486","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases.","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front Immunol"},{"key":"R17-20260923","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets.","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R18-20260923","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.3748\/wjg.v29.i18.2733","article-title":"Study of tumor necrosis factor receptor in the inflammatory bowel disease.","volume":"29","author":"Souza","year":"2023","journal-title":"World J Gastroenterol"},{"key":"R19-20260923","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease.","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ Res"},{"key":"R20-20260923","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","article-title":"Strategies for targeting cytokines in inflammatory bowel disease.","volume":"24","author":"Neurath","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"R21-20260923","doi-asserted-by":"crossref","first-page":"jjae192","DOI":"10.1093\/ecco-jcc\/jjae192","article-title":"Clinical outcomes after first-line anti-tumor-necrosis-factor treatment of patients with inflammatory bowel disease\u2014a prospective multicenter cohort study.","volume":"19","author":"Zhao","year":"2025","journal-title":"J Crohns Colitis"},{"key":"R22-20260923","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.3390\/nu14245361","article-title":"Short chain fatty acid metabolism in relation to gut microbiota and genetic variability.","volume":"14","author":"Ramos Meyers","year":"2022","journal-title":"Nutrients"},{"key":"R23-20260923","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s42255-025-01246-5","article-title":"Human gut microbial aromatic amino acid and related metabolites prevent obesity through intestinal immune control.","volume":"7","author":"Jiang","year":"2025","journal-title":"Nat Metab"},{"key":"R24-20260923","doi-asserted-by":"crossref","first-page":"1307394","DOI":"10.3389\/fmed.2024.1307394","article-title":"Exploring the role of IL-1\u03b2 in inflammatory bowel disease pathogenesis.","volume":"11","author":"Aggeletopoulou","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R25-20260923","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1093526619834807","article-title":"Genomic and immunologic drivers of very early-onset inflammatory bowel disease.","volume":"22","author":"Conrad","year":"2019","journal-title":"Pediatr Dev Pathol"},{"key":"R26-20260923","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cei\/uxac040","article-title":"The clinical, molecular, and therapeutic features of patients with IL10\/IL10R deficiency: a systematic review.","volume":"208","author":"Sharifinejad","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"R27-20260923","doi-asserted-by":"crossref","first-page":"1161067","DOI":"10.3389\/fimmu.2023.1161067","article-title":"The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions.","volume":"14","author":"Carlini","year":"2023","journal-title":"Front Immunol"},{"key":"R28-20260923","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s10753-013-9658-3","article-title":"IL-10RB rs2834167 (A\/G) polymorphism is associated with the susceptibility to systemic lupus erythematosus: evidence from a study in Chinese Han population.","volume":"36","author":"Peng","year":"2013","journal-title":"Inflammation"},{"key":"R29-20260923","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41525-022-00324-x","article-title":"A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility.","volume":"7","author":"Voloudakis","year":"2022","journal-title":"NPJ Genom Med"},{"key":"R30-20260923","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbrc.2008.06.054","article-title":"Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis.","volume":"373","author":"Hikami","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R31-20260923","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-3-030-36667-4_3","article-title":"CCL4 signaling in the tumor microenvironment.","volume":"1231","author":"Mukaida","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"R32-20260923","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00262-024-03909-w","article-title":"CCR5 and IL-12 co-expression in CAR T cells improves antitumor efficacy by reprogramming tumor microenvironment in solid tumors.","volume":"74","author":"Tian","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"R33-20260923","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41586-025-08844-z","article-title":"DNA-guided transcription factor interactions extend human gene regulatory code.","volume":"641","author":"Xie","year":"2025","journal-title":"Nature"},{"key":"R34-20260923","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10863-024-10047-6","article-title":"Acute CCl4-induced intoxication reduces complex I, but not complex II-based mitochondrial bioenergetics \u2013 protective role of succinate.","volume":"57","author":"Ikromova","year":"2025","journal-title":"J Bioenerg Biomembr"},{"key":"R35-20260923","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41401-024-01454-x","article-title":"Peptidoglycan isolated from the fruit of Lycium barbarum alleviates liver fibrosis in mice by regulating the TGF-\u03b2\/Smad7 signaling and gut microbiota.","volume":"46","author":"Nie","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"R36-20260923","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/cells14010033","article-title":"CCL4 affects eosinophil survival via the shedding of the MUC1 N-terminal domain in airway inflammation.","volume":"14","author":"Kobayashi","year":"2024","journal-title":"Cells"},{"key":"R37-20260923","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.2147\/JIR.S343491","article-title":"Direct CCL4 inhibition modulates gut microbiota, reduces circulating trimethylamine N-oxide, and improves glucose and lipid metabolism in high-fat-diet-induced diabetes mellitus.","volume":"14","author":"Chang","year":"2021","journal-title":"J Inflamm Res"},{"key":"R38-20260923","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3390\/cancers13071525","article-title":"The Flt3L\/Flt3 axis in dendritic cell biology and cancer immunotherapy.","volume":"13","author":"Cueto","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R39-20260923","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-2249.2012.04641.x","article-title":"Treatment with Fms-like tyrosine kinase 3 ligand reverses lung dendritic cell immunoparalysis and ameliorates zymosan-induced secondary lung injury in mice.","volume":"170","author":"Wang","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"R40-20260923","doi-asserted-by":"crossref","first-page":"e2250201","DOI":"10.1002\/eji.202250201","article-title":"Enhanced in vitro type 1 conventional dendritic cell generation via the recruitment of hematopoietic stem cells and early progenitors by Kit ligand.","volume":"53","author":"Ou","year":"2023","journal-title":"Eur J Immunol"},{"key":"R41-20260923","first-page":"100187","article-title":"Mutations of FLT3 receptor affect its surface glycosylation, intracellular localization, and downstream signaling.","volume":"13","author":"Takahashi","year":"2019","journal-title":"Leuk Res Rep"},{"key":"R42-20260923","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1186\/s12885-025-14220-x","article-title":"FLT3LG modulates the infiltration of immune cells and enhances the efficacy of anti-PD-1 therapy in lung adenocarcinoma.","volume":"25","author":"Zhao","year":"2025","journal-title":"BMC Cancer"},{"key":"R43-20260923","doi-asserted-by":"crossref","first-page":"1243537","DOI":"10.3389\/fimmu.2023.1243537","article-title":"Eotaxin-1\/CCL11 promotes cellular senescence in human-derived fibroblasts through pro-oxidant and pro-inflammatory pathways.","volume":"14","author":"Lavandoski","year":"2023","journal-title":"Front Immunol"},{"key":"R44-20260923","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1038\/s41388-021-02046-3","article-title":"CCL11 exacerbates colitis and inflammation-associated colon tumorigenesis.","volume":"40","author":"Polosukhina","year":"2021","journal-title":"Oncogene"},{"key":"R45-20260923","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40164-024-00505-7","article-title":"Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion.","volume":"13","author":"Lu","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"R46-20260923","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12967-024-05118-6","article-title":"Single-cell RNA sequencing reveals recruitment of the M2-like CCL8high macrophages in Lewis lung carcinoma-bearing mice following hypofractionated radiotherapy.","volume":"22","author":"Yang","year":"2024","journal-title":"J Transl Med"},{"key":"R47-20260923","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.3390\/ijms25137379","article-title":"The role of short chain fatty acids in inflammation and body health.","volume":"25","author":"Du","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R48-20260923","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41422-022-00645-7","article-title":"Gut microbiota drives macrophage-dependent self-renewal of intestinal stem cells via niche enteric serotonergic neurons [published correction appears in Cell Res. 2022 Dec;32(12):1132. doi: 10.1038\/s41422-022-00734-7].","volume":"32","author":"Zhu","year":"2022","journal-title":"Cell Res"},{"key":"R49-20260923","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"key":"R50-20260923","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1038\/s41467-025-57706-9","article-title":"PD-L1+ plasma cells suppress T lymphocyte responses in patients with sepsis and mouse sepsis models.","volume":"16","author":"Gossez","year":"2025","journal-title":"Nat Commun"},{"key":"R51-20260923","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.2147\/OTT.S221340","article-title":"The role of PD-1\/PD-L1 axis in Treg development and function: implications for cancer immunotherapy.","volume":"12","author":"Cai","year":"2019","journal-title":"Onco Targets Ther"},{"key":"R52-20260923","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3904\/kjim.2024.019","article-title":"The role of PD-1\/PD-L1 pathway in ulcerative colitis and changes following tonsil-derived mesenchymal stem cells treatment.","volume":"39","author":"Song","year":"2024","journal-title":"Korean J Intern Med"},{"key":"R53-20260923","doi-asserted-by":"crossref","first-page":"e152468","DOI":"10.1172\/jci.insight.152468","article-title":"Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors.","volume":"6","author":"Curnock","year":"2021","journal-title":"JCI Insight"},{"key":"R54-20260923","doi-asserted-by":"crossref","first-page":"811867","DOI":"10.3389\/fimmu.2022.811867","article-title":"TNF-\u03b1-secreting lung tumor-infiltrated monocytes play a pivotal role during anti-PD-L1 immunotherapy.","volume":"13","author":"De Ridder","year":"2022","journal-title":"Front Immunol"},{"key":"R55-20260923","doi-asserted-by":"crossref","first-page":"e15481","DOI":"10.7717\/peerj.15481","article-title":"The significance of PD-1\/PD-L1 imbalance in ulcerative colitis.","volume":"11","author":"Shi","year":"2023","journal-title":"PeerJ"},{"key":"R56-20260923","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1091\/mbc.E17-08-0535","article-title":"Unbalanced lipolysis results in lipotoxicity and mitochondrial damage in peroxisome-deficient Pex19 mutants.","volume":"29","author":"B\u00fclow","year":"2018","journal-title":"Mol Biol Cell"},{"key":"R57-20260923","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/s41467-025-57405-5","article-title":"Proximity proteomics reveals a mechanism of fatty acid transfer at lipid droplet-mitochondria-endoplasmic reticulum contact sites.","volume":"16","author":"Bezawork-Geleta","year":"2025","journal-title":"Nat Commun"},{"key":"R58-20260923","doi-asserted-by":"crossref","first-page":"1269581","DOI":"10.3389\/fphar.2023.1269581","article-title":"From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration.","volume":"14","author":"Afzal","year":"2023","journal-title":"Front Pharmacol"},{"key":"R59-20260923","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s40001-025-02424-7","article-title":"Resolvin D1 accelerates resolution of neuroinflammation by inhibiting microglia activation through the BDNF\/TrkB signaling pathway.","volume":"30","author":"Bo","year":"2025","journal-title":"Eur J Med Res"},{"key":"R60-20260923","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/biomedicines10010044","article-title":"Restoring the balance between pro-inflammatory and anti-inflammatory cytokines in the treatment of rheumatoid arthritis: new insights from animal models.","volume":"10","author":"Markovics","year":"2021","journal-title":"Biomedicines"},{"key":"R61-20260923","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/ibd\/izad161","article-title":"GPR120\/FFAR4: a potential new therapeutic target for inflammatory bowel disease.","volume":"29","author":"Di Petrillo","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"R62-20260923","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00394-024-03468-x","article-title":"Docosahexaenoic acid (DHA) alleviates inflammation and damage induced by experimental colitis.","volume":"63","author":"Ariturk","year":"2024","journal-title":"Eur J Nutr"},{"key":"R63-20260923","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7150\/ijbs.16404","article-title":"The protective effect of alpha 7 nicotinic acetylcholine receptor activation on critical illness and its mechanism.","volume":"13","author":"Ren","year":"2017","journal-title":"Int J Biol Sci"},{"key":"R64-20260923","doi-asserted-by":"crossref","first-page":"117534","DOI":"10.1016\/j.ecoenv.2024.117534","article-title":"Anisodamine ameliorates crystalline silica-exposed pulmonary inflammation and fibrosis via the \u03b17nAChR\/JAK2\/STAT3 signaling pathway.","volume":"289","author":"Liu","year":"2025","journal-title":"Ecotoxicol Environ Saf"},{"key":"R65-20260923","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10067-025-07320-3","article-title":"GTS-21 modulates rheumatoid arthritis Th17 and Th2 lymphocyte subset differentiation through the \u02517nAch receptor.","volume":"44","author":"Wu","year":"2025","journal-title":"Clin Rheumatol"},{"key":"R66-20260923","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.jbchem.a003101","article-title":"Phospholipase A2.","volume":"131","author":"Murakami","year":"2002","journal-title":"J Biochem"},{"key":"R67-20260923","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1007\/s10620-024-08588-2","article-title":"Homocysteine promotes intestinal inflammation in colitis mice through the PGE2\/STAT3 signaling pathway [published correction appears in Dig Dis Sci. 2025 Mar 5. doi: 10.1007\/s10620-025-08903-5].","volume":"69","author":"Shao","year":"2024","journal-title":"Dig Dis Sci"},{"key":"R68-20260923","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41419-021-04293-4","article-title":"Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4\/MyD88\/AKT\/NF-\u03baB pathway in pancreatic cancer.","volume":"12","author":"Yin","year":"2021","journal-title":"Cell Death Dis"},{"key":"R69-20260923","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.3390\/ijms221910224","article-title":"Gut microbiota and dietary factors as modulators of the mucus layer in inflammatory bowel disease.","volume":"22","author":"Fern\u00e1ndez-Tom\u00e9","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R70-20260923","doi-asserted-by":"crossref","first-page":"184254","DOI":"10.1016\/j.bbamem.2023.184254","article-title":"Study of the correlation between the structure of selected triester of phosphatidylcholine and their impact on physicochemical properties of model mammalian membranes.","volume":"1866","author":"Mach","year":"2024","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"R71-20260923","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12944-025-02592-9","article-title":"Association between saturated and polyunsaturated fatty acid proportions in total fat intake and mortality risk: mediation by the neutrophil percentage-to-albumin ratio.","volume":"24","author":"Liu","year":"2025","journal-title":"Lipids Health Dis"},{"key":"R72-20260923","doi-asserted-by":"crossref","first-page":"e0156387","DOI":"10.1371\/journal.pone.0156387","article-title":"Serum fatty acids are correlated with inflammatory cytokines in ulcerative colitis.","volume":"11","author":"Wiese","year":"2016","journal-title":"PLoS One"},{"key":"R73-20260923","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/biomedicines11020280","article-title":"The modulatory effects of fatty acids on cancer progression.","volume":"11","author":"Westheim","year":"2023","journal-title":"Biomedicines"},{"issue":"Part A","key":"R74-20260923","doi-asserted-by":"crossref","first-page":"101946","DOI":"10.1016\/j.fbio.2022.101946","article-title":"Oat phenolic compounds regulate metabolic syndrome in high fat diet-fed mice via gut microbiota.","volume":"50","author":"Dong","year":"2022","journal-title":"Food Biosci"},{"key":"R75-20260923","doi-asserted-by":"crossref","first-page":"12686","DOI":"10.1039\/D2FO01746F","article-title":"Whole grain benefit: synergistic effect of oat phenolic compounds and \u03b2-glucan on hyperlipidemia via gut microbiota in high-fat-diet mice.","volume":"13","author":"Li","year":"2022","journal-title":"Food Funct"},{"key":"R76-20260923","doi-asserted-by":"crossref","first-page":"jjae148","DOI":"10.1093\/ecco-jcc\/jjae148","article-title":"Oxidized polyunsaturated fatty acid promotes colitis and colitis-associated tumorigenesis in mice.","volume":"19","author":"Wang","year":"2025","journal-title":"J Crohns Colitis"},{"key":"R77-20260923","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets.","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"R78-20260923","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/1871527321666220103204515","article-title":"Arachidonic acid mediators and their role in neurological disease.","volume":"21","author":"Hoxha","year":"2022","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R79-20260923","doi-asserted-by":"crossref","first-page":"793582","DOI":"10.3389\/fimmu.2022.793582","article-title":"RNA 2\u2032-O-methyltransferase fibrillarin facilitates virus entry into macrophages through inhibiting type I interferon response.","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"R80-20260923","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1158\/0008-5472.CAN-19-3184","article-title":"Consumption of the fish oil high-fat diet uncouples obesity and mammary tumor growth through induction of reactive oxygen species in protumor macrophages.","volume":"80","author":"Liu","year":"2020","journal-title":"Cancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:01:41Z","timestamp":1790186501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":80,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044206","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}